Hints and tips:
Related Special Reports
...BioNTech and Pfizer have described a similar patent filed in the US as “unimaginably broad” in American proceedings....
...generics manufacturer said....
...Ninety-one per cent of drugs prescribed in the US and 70 per cent in Europe are generics and biosimilars, a more complex off-patent drug....
...The move comes after the US International Trade Commission issued a “limited exclusion order” against the products in October, threatening a ban on imports of the devices....
...Some drugmakers have warned that prices for off-patent, generic medicines are now so low it has become unattractive to continue making them. Generics make up the majority of drugs used globally....
...But it had better luck before the International Trade Commission, a body set up more than a century ago to manage US tariffs....
...Apple will stop selling its smartwatches through the company’s own US stores before Christmas after losing a patent infringement case, dealing it a blow during the holiday sales season....
...The International Trade Commission confirmed in October that Apple was violating Masimo’s patents with the latest versions of its Watch and issued a limited exclusion order, prompting the company to pull...
...Apple confirmed on Tuesday that it had appealed against the earlier ruling from the US International Trade Commission, which stems from a patent dispute with health technology company Masimo....
...The ITC, a US government agency, sided with Masimo, finding Apple had infringed on its patents and barring sales of the affected models within the US....
...Described as the “soft launch” of American Riviera Orchard, the Duchess was revealing a new company whose US patent registration mentions jams and jellies, plus other items including tableware, kitchen linens...
...The US economy added over 350,000 jobs in January, and the details of the report looked healthy, too....
...The International Trade Commission ruled in October that Apple was violating Masimo’s patents with the latest versions of its Watch, prompting the company to pull the devices from its online and physical...
...Jeff Yass’s Susquehanna International Group first invested $80,000 in ByteDance, the Chinese owner of TikTok, on the back of an idea sketched on a napkin in a Beijing coffee shop more than a decade ago....
...Bishop said Apple was already enforcing the filing requirement for Chinese developer accounts, and was required to do so for international services....
...Sales of electric vehicles will “grow strongly” this year and could see battery and hybrid models account for one in five cars sold worldwide, according to a bullish forecast from the International Energy...
...PGIA, the US division of Australia’s Perpetual, filed for similar relief in February last year, even before the May expiry of Vanguard’s 22-year patent on the structure....
...Teva previously targeted generic drug creation for 80 per cent of products coming to the end of patent exclusivity. Francis wants to reduce that ratio to 60 per cent....
...The Swiss pharmaceuticals group is following many rivals to focus its operations on higher-value innovative treatments rather than the cheaper off-patent drugs made by Sandoz, including generic versions...
...Kisqali and Kesimpta also face patent expiries two years later in 2031. In total, Novartis will have to replace more than $10bn of sales between 2027 and the end of 2032, estimates UBS....
...Off-patent generic medicines make up the backbone of pharmaceutical care, but manufacturing issues, weak supply chains and low pricing have combined to create a “broken market” that makes these treatments...
...His quant trading firm Susquehanna International Group owns roughly 15 per cent of the company, and the stake represents a significant chunk of his net worth....
...PGIA, the US division of Australia’s Perpetual, filed for similar relief in February, even before the May sunset of Vanguard’s 22-year patent on the structure....
International Edition